Features like DNA Relatives, which match you with genetic relatives in 23andMe's database, are opt-in, meaning you control whether your data is used to identify and connect you with biological relatives.
This analysis describes what 23andMe's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision operationalizes user control over a specific category of data processing—the matching and display of genetic information across the service's user base. The mechanism distinguishes between passive data collection and active matching/sharing functionality, with the latter contingent on affirmative user election.
Interpretive note: The full scope of what information is visible to matched relatives and the specific consent language presented at opt-in is not detailed in the document excerpt reviewed.
The updated privacy statement no longer explicitly directs users to a separate Medical Record Privacy Notice for telehealth services or explains that medical information collected through telehealth is governed by different privacy rules. Previously, the policy stated that users choosing telehealth services coordinated through 23andMe would find healthcare privacy protections described in a separate notice. That reference is now absent from the main privacy statement. Users seeking privacy information specific to telehealth services will need to determine independently whether a separate notice exists or contact 23andMe directly using the provided contact information.
View change record →The updated privacy statement no longer explicitly discloses a separate Medical Record Privacy Notice that previously described how medical information is used, disclosed, and maintained for telehealth services. Users who receive telehealth services coordinated through 23andMe may now lack clear notice of which privacy framework governs their medical records, since the reference to that parallel notice has been removed. The organizational scope change from '23andMe Research Institute' to '23andMe' narrows the explicitly named entities responsible for the policy, though operational impact depends on how these entities actually function.
View change record →Enabling DNA Relatives allows 23andMe to match your genetic data against its full user database to identify biological relatives; this can reveal sensitive family information that cannot be unknown once discovered, and also makes your partial genetic profile visible to matched relatives.
How other platforms handle this
TrustArcWrapper.withTrustArc(analytics, { alwaysLoadSegment: true }).load(segmentKey, cookieConfig);
At Ledger, earning and maintaining our users' trust is a top priority. That's why we are deeply committed not only to protecting your privacy and securing your personal data, but also to being fully transparent about how we handle it.
If you are located in the European Economic Area, Switzerland, or the United Kingdom, you have the right to access, correct, or erase your personal data; the right to restrict or object to our processing of your personal data; the right to data portability; and, where our processing is based on your...
Monitoring
23andMe has changed this document before.
Receive same-day alerts, structured change summaries, and monitoring for up to 25 platforms.
"You decide whether you want to participate in our sharing features, like DNA Relatives and Your Connections.— Excerpt from 23andMe's 23andMe Privacy Statement
REGULATORY LANDSCAPE: The DNA Relatives feature involves sharing partial genetic profile information with third-party users (matched relatives), which may constitute a data disclosure under GDPR and CCPA. The consent mechanism for this feature is operationally critical; under GDPR, the sharing of genetic data with other identifiable individuals requires explicit consent and adequate transparency about what information is shared and with whom. The FTC's consumer protection framework applies to the adequacy of disclosures about this feature. GOVERNANCE EXPOSURE: Medium. The feature is opt-in, which is a positive consent design element. However, the implications of the feature, including the possibility of discovering unexpected family relationships and the fact that matched relatives can see partial profile information, require careful disclosure to satisfy GDPR transparency requirements and avoid claims of unfair or deceptive practices. JURISDICTION FLAGS: EU/EEA users have GDPR rights regarding the sharing of their genetic data with other identified or identifiable individuals. California users have CCPA rights regarding disclosure of personal information to third parties. The emotional and social consequences of unexpected family discoveries through this feature may create additional exposure in jurisdictions with strong consumer protection frameworks. CONTRACT AND VENDOR IMPLICATIONS: The feature creates a user-to-user data sharing dynamic that is distinct from company-to-third-party sharing; governance frameworks should address what data is visible to matched relatives, what privacy controls exist for each participant, and how disputes about unwanted contact or disclosures are handled. COMPLIANCE CONSIDERATIONS: The consent and disclosure mechanisms for DNA Relatives should be reviewed to ensure users fully understand what information will be visible to matched relatives and what personal implications may arise. The opt-in design is consistent with best practices for sensitive data sharing, but the adequacy of the explanatory information provided at the point of consent should be evaluated.
Full compliance analysis
Regulatory citations, enforcement risk, and due diligence action items.
Free: track 1 platform + weekly digest. Monitor: 25 platforms + same-day alerts. No credit card required.
Ad personalization controls removed. Contact scanning added. Advertiser data partnerships quietly dropped. A timeline of every change.
Compliance Governance Intelligence
Need to monitor specific governance provisions?
Compliance includes provision-level monitoring, governance timelines, regulatory mapping, and audit-ready analysis.
Built from archived source documents, structured governance mappings, and historical version tracking.
This provision operationalizes user control over a specific category of data processing—the matching and display of genetic information across the service's user base. The mechanism distinguishes between passive data collection and active matching/sharing functionality, with the latter contingent on affirmative user election.
Enabling DNA Relatives allows 23andMe to match your genetic data against its full user database to identify biological relatives; this can reveal sensitive family information that cannot be unknown once discovered, and also makes your partial genetic profile visible to matched relatives.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by 23andMe.